Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816127 · ClinicalTrials.gov registry record · NA
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00816127 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 36 participants.
The verdict
NCT00816127, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how effective and cost saving 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of blood products in preventing bleeding after teeth extraction in persons with severe liver disease being evaluated for liver transplant.
Interventions
- DRUG Desmopressin
- BIOLOGICAL blood transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00816127
The ClinicalTrials.gov registry entry for NCT00816127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Desmopressin is the first listed.
NCT00816127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00816127 about?
NCT00816127 is a clinical study titled "Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction". The purpose of this study is to investigate how effective and cost saving 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of blood products in preventing bleeding after teeth extraction in persons with severe liver disease being evaluated for liver transplan...
What is the current status of trial NCT00816127?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2003-10. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00816127?
The interventions under investigation include: Desmopressin (DRUG), blood transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT00816127?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.